JAMA. 2022 May 10; 327 (18) : 1812-1816. PMID:35536261

        Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

        Elizabeth M Webber, Jennifer S Lin, Rachel G Thomas

        该不该实施某项疾病预防策略?事实说话。会不会时过境迁?重审数据，再决策。

        慢阻肺筛查关注的焦点在于筛出来的患者准备怎么办?就目前的治疗手段，在轻度气流受限患者(构成筛查对象即“40岁及以上没有意识到或报告症状的成人”的主要部分)获益细微，治疗相关不良反应不是没有。当然，这是将筛查对象作为一个群体来考虑。

        JAMA. 2022 May 10; 327 (18) : 1806-1811. PMID:35536260

        Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement.

        Carol M Mangione, Michael J Barry, Wanda K Nicholson, et al

        第6大死因，筛查“没有净效益”就可以不管了吗?仔细看，不是的，控烟普适于每个个体，无论他/她是不是接受慢阻肺筛查。

        European Respiratory Journal. 2022 Mar 24; PMID:35332067

        Derivation and Validation of the UCAP-Q Case-finding Questionnaire to Detect Undiagnosed Asthma and COPD.

        Chau Huynh, G A Whitmore, Katherine L Vandemheen, et al

        在治疗价值明确的疾病人群中优化早期诊断手段，也就是说治疗获益大于风险的患者须尽早予以诊断、减少漏诊。Case-finding questionnaire已习惯性翻译成“筛查问卷”，但本文“筛查”的目标人群显然不同于USPSTF推荐意见中“无症状”人群的screening，可见一项措施只有明确界定了其施用对象，才能发挥其预期效能。

        Chest. 2022 Apr 22; PMID: 35469854

        The Contribution of Anthropometry and Socioeconomic Status to Racial Differences in Measures of Lung Function: A Systematic Review.

        Rachel Holland, Cole Bowerman, Sanja Stanojevic

        预计值公式真是个难题

        European Respiratory Journal. 2022 Apr 29;PMID: 35487537

        Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150000 European children.

        Evelien R van Meel, Sara M Mensink-Bout, Herman T den Dekker, et al